Manulife (Manufacturers Life Insurance)
AZN icon

Manulife (Manufacturers Life Insurance)’s AstraZeneca AZN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$687M Sell
3,673,390
-171,150
-4% -$32.2M 0.54% 33
2026
Q1 		$745M Buy
3,844,540
+3,789,695
+6,910% +$731M 0.64% 26
2025
Q4 		$10.1M Sell
54,845
-4,569
-8% -$801K 0.01% 862
2025
Q3 		$9.12M Buy
59,414
+9,919
+20% +$1.5M 0.01% 901
2025
Q2 		$6.92M Buy
49,495
+6,253
+14% +$876K 0.01% 1014
2025
Q1 		$6.36M Sell
43,242
-55,321
-56% -$8M 0.01% 1052
2024
Q4 		$12.9M Sell
98,563
-3,644
-4% -$510K 0.01% 765
2024
Q3 		$15.9M Sell
102,207
-1,016
-1% -$164K 0.01% 688
2024
Q2 		$16.1M Buy
103,223
+29,019
+39% +$4.37M 0.02% 673
2024
Q1 		$10.1M Buy
74,204
+16,444
+28% +$2.18M 0.01% 855
2023
Q4 		$7.78M Buy
57,760
+10,981
+23% +$1.43M ﹤0.01% 953
2023
Q3 		$6.34M Buy
+46,779
New +$6.39M ﹤0.01% 1008
2018
Q4 		– Sell
-3,869
Closed -$306K – 2528
2018
Q3 		$306K Sell
3,869
-2,803
-42% -$212K ﹤0.01% 2532
2018
Q2 		$468K Sell
6,672
-207
-3% -$14.9K ﹤0.01% 2450
2018
Q1 		$481K Sell
6,879
-1,701
-20% -$118K ﹤0.01% 2360
2017
Q4 		$595K Sell
8,580
-189
-2% -$12.7K ﹤0.01% 2204
2017
Q3 		$594K Buy
8,769
+1,412
+19% +$89.2K ﹤0.01% 2147
2017
Q2 		$502K Buy
7,357
+664
+10% +$43.4K ﹤0.01% 2284
2017
Q1 		$417K Buy
6,693
+3,646
+120% +$212K ﹤0.01% 2322
2016
Q4 		$167K Buy
3,047
+375
+14% +$21.3K ﹤0.01% 2929
2016
Q3 		$175K Buy
2,672
+404
+18% +$26.4K ﹤0.01% 2870
2016
Q2 		$137K Buy
2,268
+647
+40% +$37.6K ﹤0.01% 3023
2016
Q1 		$92K Buy
1,621
+1,532
+1,721% +$92.1K ﹤0.01% 3082
2015
Q4 		$6 Sell
89
-976
-92% -$64K ﹤0.01% 3620
2015
Q3 		$68 Sell
1,065
-4,506
-81% -$296K ﹤0.01% 3257
2015
Q2 		$177 Sell
5,571
-62
-1% -$4.25K ﹤0.01% 2956
2015
Q1 		$193 Buy
5,633
+1,136
+25% +$78.9K ﹤0.01% 2763
2014
Q4 		$317 Buy
+4,497
New +$322K ﹤0.01% 2300
2013
Q3 		– Sell
-11,630
Closed -$550K – 3687
2013
Q2 		$550K Buy
+11,630
New +$592K ﹤0.01% 1826

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AZN Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its AstraZeneca (AZN) stake by 4.5% in Q2 2026, selling an estimated $32.2M and leaving 3,673,390 shares worth $687M. The position accounts for 0.54% of the portfolio, ranked #33.

Manulife (Manufacturers Life Insurance) first reported a position in AZN in Q2 2013 and has held it in 29 quarters since. The position peaked at $745M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 3,673,390 shares of AstraZeneca worth $687M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 171,150 AstraZeneca shares in Q2 2026, an estimated $32.2M.
  • AstraZeneca made up 0.54% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #33 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in AstraZeneca in Q2 2013 and has held it in 29 quarters since.
  • Manulife (Manufacturers Life Insurance)'s AstraZeneca position peaked at $745M in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.